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Varga ZV, Zvara Á, Faragó N, Kocsis GF, Pipicz M, Gáspár R,
Bencsik P, Görbe A, Csonka C, Puskás LG, Thum T, Csont T, Ferdi-
nandy P. MicroRNAs associated with ischemia-reperfusion injury and
cardioprotection by ischemic pre- and postconditioning: protectomiRs. Am J
Physiol Heart Circ Physiol 307: H216–H227, 2014. First published May 23,
2014; doi:10.1152/ajpheart.00812.2013.—We aimed to characterize early
changes in microRNA expression in acute cardioprotection by isch-
emic pre- and postconditioning in rat hearts. Hearts isolated from male
Wistar rats were subjected to 1) time-matched nonischemic perfusion,
2) ischemia-reperfusion (30 min of coronary occlusion and 120 min of
reperfusion), 3) preconditioning (3  5 min of coronary occlusion)
followed by ischemia-reperfusion, or 4) ischemia-reperfusion with
postconditioning (6 10 s of global ischemia-reperfusion at the onset
of reperfusion). Infarct size was significantly reduced by both inter-
ventions. Of 350 different microRNAs assessed by microarray anal-
ysis, 147–160 microRNAs showed detectable expression levels. Com-
pared with microRNA alterations induced by ischemia-reperfusion
versus time-matched nonischemic controls, five microRNAs were
significantly affected by both pre- and postconditioning (microRNA-
125b*, microRNA-139-3p, microRNA-320, microRNA-532-3p, and
microRNA-188), four microRNAs were significantly affected by
preconditioning (microRNA-487b, microRNA-139-5p, microRNA-
192, and microRNA-212), and nine microRNAs were significantly
affected by postconditioning (microRNA-1, microRNA let-7i,
microRNA let-7e, microRNA let-7b, microRNA-181a, microRNA-208, mi-
croRNA-328, microRNA-335, and microRNA-503). Expression of
randomly selected microRNAs was validated by quantitative real-time
PCR. By a systematic comparison of the direction of microRNA
expression changes in all groups, we identified microRNAs, specific
mimics, or antagomiRs that may have pre- and postconditioning-like
cardioprotective effects (protectomiRs). Transfection of selected pro-
tectomiRs (mimics of microRNA-139-5p, microRNA-125b*,
microRNA let-7b, and inhibitor of microRNA-487b) into cardiac myocytes
subjected to simulated ischemia-reperfusion showed a significant
cytoprotective effect. This is the first demonstration that the ischemia-
reperfusion-induced microRNA expression profile is significantly in-
fluenced by both pre- and postconditioning, which shows the involve-
ment of microRNAs in cardioprotective signaling. Moreover, by
analysis of microRNA expression patterns in cardioprotection by pre-
and postconditioning, specific protectomiRs can be revealed as po-
tential therapeutic tools for the treatment of ischemia-reperfusion
injury.
microRNA; miRNA; miR; reperfusion injury; cardioprotection
MICRORNAS ARE SMALL (19–23 nucleotides) noncoding RNA
molecules that are currently being recognized as endogenous
physiological regulators of gene expression (1). It has been
well established that microRNAs play an essential role in the
posttranscriptional regulation of gene expression by repression
or activation of translation/transcription (“RNA interference”)
(5, 27). MicroRNAs are known to play important roles in many
physiological and pathological processes in the heart, including
cardiac fibrosis, the hypertrophic response, myocyte contrac-
tility, cardiac development, and arrhythmogenesis (36). Re-
cently, several research groups have reported the involvement
of some microRNAs in the pathophysiology of myocardial
infarction (11, 31). The importance of microRNAs in cardiac
pathologies suggests their promising therapeutic potential (15,
19). Modulation of microRNA expression in vivo with specific
synthetic oligonucleotides is a feasible approach, as appli-
cation of both microRNA inhibitors (antagomiRs) and mi-
croRNA mimics offer a potential therapeutic option for
cardioprotection (35).
However, little is known on the role of microRNAs in the
ischemic myocardium, particularly in the early phase of
myocardial ischemia-reperfusion (I/R) injury and in endog-
enous cardioprotective maneuvers such as ischemic pre- and
postconditioning. These cardioprotective interventions, es-
pecially ischemic postconditioning, has emerged as a clinically
applicable approach for limiting myocardial injury in humans
(30). However, despite of intensive research in the last de-
cades, the exact biological mechanisms underlying the cardio-
protective effect of pre- and postconditioning remain largely
unclear due to the complexity of the cellular events and the
interference of other comorbidities and risk factors of ischemic
heart diseases (17, 30). Therefore, the use of systems biological
tools seems necessary to reveal the complex molecular events.
Accordingly, we have previously shown by cDNA microarrays
that ischemic preconditioning (29) and ischemic postcondition-
ing (10) markedly influenced the gene expression pattern of rat
hearts.
In the present study, we aimed to identify microRNAs
involved in pre- and postconditioning-induced cardioprotec-
tion by the application of a systematic comparison of the
microRNA expression patterns of different myocardial pheno-
types, including nonischemic, I/R, protected by preconditioning,
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and protected by postconditioning. In fact, preceding ischemic
preconditioning and subsequent postconditioning stimuli can be
considered as effective “inhibitors” of I/R injury. Therefore, by
comparing microRNA expression changes and the direction of the
changes (i.e., down- or upregulation) induced by I/R versus
time-matched nonischemic controls and in I/R with pre- or
postconditioning, respectively, we were able to reveal possible
causative relationships between microRNA changes and en-
dogenous cardioprotection. Using microRNA microarrays of
350 known rat microRNA genes, in the present study, we
identified several microRNAs associated with cardioprotection
by ischemic pre- and postconditioning. These microRNAs are
potential therapeutic targets for cardioprotection, appropriate
mimics, or antagomiRs, which were termed here as “protecto-
miRs.” Validation of four of the potential protectomiRs was
also performed in cardiomyocytes subjected to simulated I/R in
vitro.
MATERIALS AND METHODS
This investigation conformed with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals (NIH Pub. No.
85-23, Revised 1996) and was approved by local animal ethics
committee of the University of Szeged.
Experimental Protocol
Male Wistar rats (250–300 g) were anesthetized with diethyl ether
and given 500 U/kg heparin intravenously. Hearts were then isolated
and perfused according to Langendorff with oxygenated, normother-
mic Krebs-Henseleit buffer as previously described (9). Four different
perfusion protocols were applied (Fig. 1). A time-matched nonisch-
emic control group was aerobically perfused for 190 min. In the I/R
group, regional ischemia was induced by 30 min of occlusion of the
left anterior descending coronary artery (LAD) followed by 120 min
of reperfusion. In the preconditioning group, hearts were subjected to
a preconditioning protocol (induced by three intermittent cycles of 5
min of coronary occlusion/5 min of reperfusion) followed by I/R. In
the postconditioning group, postconditioning was induced by six
consecutive cycles of 10 s of global ischemia and 10 s of reperfusion
applied immediately at the onset of the 120 min of reperfusion. Heart
rate and coronary flow were monitored throughout the perfusion
protocol in all groups. To assess I/R injury and cardioprotection,
infarct size was determined by planimetry (Infarctsize 2.4, Pharma-
hungary, Szeged, Hungary) after standard triphenyltetrazolium chlo-
ride staining at the end of reperfusion (n  8–10/group). Infarct size
was expressed as a percentage of the area at risk (8). To further assess
tissue injury, lactate dehydrogenase (LDH) release of hearts was
measured using a LDH-P kit (Diagnosticum, Budapest, Hungary)
from coronary effluents collected for 5 min upon reperfusion after test
ischemia (n 12/group). LDH release was expressed as milliunits per
minute per gram wet heart weight. In separate experiments, at the end
of the 120 min of reperfusion, we sampled the LAD-supplied risk
zone of the left ventricle for further analysis of microRNA expression.
Sampling was performed by a single oblique cut with scissors from
the origin of the LAD toward the right side of the apical area that
involves the majority of the anterior wall of the left ventricle as well
as the apex of the heart. Samples from all groups (n  6/group) were
rapidly frozen in liquid nitrogen for microRNA isolation.
MicroRNA Isolation
MicroRNA isolation was performed according to the protocol for
isolation of microRNA from tissues as supplied in the manufacturer’s
kit (Roche) with some modifications (14). RNA quality and quantity
were assessed spectrophotometrically (Nanodrop) with a 2100 Bio-
analyzer (Agilent).
Microarray Analysis of MicroRNA Expression
MicroRNAs were labeled using the miRNA Complete Labeling
and Hyb kit system (Agilent Technologies, Palo Alto, CA). Labeled
samples were completely vacuum dried on the medium-high (45°C)
heat setting and hybridized onto the surface of a 8  15k Rat miRNA
Microarray (Agilent Technologies), which was done in microarray
hybridization chambers (Agilent Technologies), as previously de-
scribed (13). Each array was scanned as previously described (16).
Statistical analysis was performed on fluorescent signal intensity data
representing microRNA expression, as described below.
Changes in gene expression were determined as ratios of signal
intensity values. For visual comparison and representation of both
down- and upregulation, data were shown as log2 changes. Averages
of log2 changes were plotted with SD values.
30 min
40 min
Ischemia/reperfusion (IR)
120 min
Time-matched, non-ischemic control (C)
190 min
30 min
Ischemic preconditioning (PRE)
120 min
5’ 5’ 5’
30 min
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Ischemic postconditioning (POST)
120 min
10’ 5’ 5’ 5’
6x10” I/R
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tissue sampling for microRNA assays 
Global ischemia cycles to induce POST
Fig. 1. Experimental protocol. Hearts isolated from
male Wistar rats were subjected to either time-
matched aerobic perfusion [i.e., time-matched non-
ischemic control (C)], 30 min of coronary occlusion
and 120 min of reperfusion [ischemia/reperfusion
(I/R; IR)], 3  5 min of I/R followed by 30 min of
coronary occlusion and 120 min of reperfusion [pre-
conditioning (PRE)], or 6  10 s of global I/R
applied immediately after 30 min of coronary oc-
clusion and followed by 120 min of reperfusion
[postconditioning (POST)] protocols. Coronary ef-
fluent was collected upon the first 5 min of reper-
fusion after coronary occlusion for lactate dehydro-
genase release detection. Infarct size was measured
at the 120th min of reperfusion. For microRNA
isolation, in separate experiments, left ventricles
were frozen in liquid nitrogen at the end of the
perfusion protocol.
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Validation of Microarray Data by Quantitative Real-Time PCR
To confirm microarray results, quantitative real-time PCR was used
on randomly selected microRNAs, as previously described (12).
Experiments were performed with the TaqMan MicroRNA Reverse
Transcription Kit (Applied Biosystems) and with TaqMan MicroRNA
Assays (Applied Biosystems).
Identification of ProtectomiRs
Ischemic preconditioning and postconditioning can be considered
as effective “inhibitors” of I/R injury. Therefore, by comparing
microRNA expression changes and the direction of the changes (i.e.,
down- or upregulation) induced by I/R versus time-matched nonisch-
emic controls and in I/R with pre- or postconditioning, respectively,
possible causative relationships between microRNA changes and
endogenous cardioprotection can be revealed. Accordingly, we first
selected microRNAs that were significantly affected by ischemic
preconditioning and/or ischemic postconditioning compared with I/R
versus nonischemic controls. These microRNAs were then divided
into three groups according to the effect of I/R compared with
time-matched nonischemic controls and further subdivided into two
additional categories according to the direction of microRNA expres-
sion changes, thereby yielding the following six categories.
Category 1. MicroRNAs that were downregulated by I/R compared
with time-matched nonischemic controls but their downregulation
was inhibited by ischemic preconditioning and/or ischemic postcon-
ditioning were considered to be associated with the cardioprotective
mechanism of ischemic preconditioning and/or ischemic postcondi-
tioning. Therefore, these microRNAs or their mimics are considered
as protectomiRs.
Category 2. MicroRNAs that were downregulated by I/R compared
with time-matched nonischemic controls but their down-regulation
was further enhanced by ischemic preconditioning and/or ischemic
postconditioning were considered to be associated with the cardio-
protective mechanism of ischemic preconditioning and/or ischemic
postconditioning. Therefore, the antagomiRs of these microRNAs can
also be considered as protectomiRs. However, no example of this
microRNA group was found.
Category 3. MicroRNAs that were upregulated by I/R compared
with time-matched nonischemic controls but their upregulation was
inhibited by ischemic preconditioning and/or ischemic postcondition-
ing were considered to be associated with the development of I/R
injury. Therefore, the antagomiRs of these microRNAs can be also
considered as protectomiRs.
Category 4. MicroRNAs that were upregulated by I/R compared
with time-matched nonischemic controls but their up-regulation was
further enhanced by ischemic preconditioning and/or ischemic post-
conditioning were considered to be associated with the cardioprotec-
tive mechanism of ischemic preconditioning and/or ischemic postcon-
ditioning. Therefore, these microRNAs or their mimics are considered
as protectomiRs.
Category 5. MicroRNAs that were not affected by I/R alone
compared with time-matched nonischemic controls but were signifi-
cantly upregulated by ischemic preconditioning and/or ischemic
postconditioning were considered to be associated with the cardio-
protective mechanism of ischemic preconditioning and/or ischemic
postconditioning. Therefore, these microRNAs or their mimics are
considered as protectomiRs.
Category 6. This group of microRNAs was not affected by I/R
alone compared with time-matched nonischemic controls but was
downregulated by ischemic preconditioning and/or ischemic postcon-
ditioning. Inhibition of these microRNAs was considered to be asso-
ciated with the cardioprotective mechanism of ischemic precondition-
ing and/or ischemic postconditioning. Therefore, the antagomiRs of
these microRNAs can be also considered as protectomiRs.
MicroRNA Transfection into Rat Cardiac Myocytes Subjected to
Simulated I/R
To validate the cytoprotective effect of selected protectomiRs,
neonatal cardiomyocyte cultures were prepared from newborn Wistar
rats (40). Cells were kept in a standard CO2 incubator (5% CO2) and
supplied with proliferation medium for 1 day (DMEM  10% FBS).
Differentiation medium (DMEM  1% FBS) was then administered
for 2 days.
Synthetized microRNAs (Dharmacon) were transfected into cardi-
omyocytes using a previously described transfection protocol (40).
Miridian microRNA mimics were diluted in antibiotic-free medium
and were incubated with cells for 10 h with DharmaFect 1 transfection
reagent, which was followed by a 10-h-long recovery period. For
negative control transfection, cel-miR-67 (a nontargeting Caenorhab-
ditis elegans microRNA) was used, which shows no sequence identity
to known rat microRNAs. After completion of the transfection pro-
cedure, transfected cells were subjected to a simulated I/R protocol.
To simulate ischemic conditions, the culture medium was changed to
hypoxic solution, plates were placed into a hypoxic chamber, and cells
were exposed to a constant flow of a mixture of 95% N2 and 5% CO2
at 37°C for 4 h. Simulated ischemia was followed by 2 h of simulated
reperfusion using differentiation medium and normoxia. To assess cell
viability, cardiomyocytes were incubated with 1 M calcein AM
(Sigma, St. Louis, MO) at room temperature for 30 min. Fluorescence
intensity was measured with a fluorescence plate reader (Fluostar
Optima, BMG Labtech, Ortenberg, Germany) with 490-nm excitation
and 520-nm emission filters. The cytoprotective effect of different
microRNA modulators was compared with the negative control, i.e.,
cardiomyocytes transfected with a nontargeting microRNA and sub-
jected to simulated I/R. We expressed viability as a percentage of
nontargeting microRNA-transfected normoxic control groups.
Statistical Analysis
Microarray and quantitative real-time PCR data are presented as
means  SD; all other data are means  SE. One-way ANOVA
followed by Fisher’s least-significant-difference post hoc test was
used to evaluate differences in mean values of infarct size, LDH
release, and hemodynamic parameters between groups.
Statistical analysis of microRNA microarrays were done as previ-
ously described using Feature Extraction software (Agilent Technol-
ogies) (14). All individual microRNAs were represented by 20 dif-
ferent probes on the array. A microRNA was considered as detected
if at least 1 probe from all 20 probes was detected. The total gene
signal is equal to the sum of all signals of the individual probes.
Expressions of all 350 microRNAs found in the Sanger miRBase
(version 10.1) were checked. Using a two-tailed two-sample unequal
variance Student’s t-test, the P value was determined to find signifi-
cant gene expression changes. A corrected P value was determined for
each gene to control the false discovery rate using the Benjamini and
Hochberg multiple testing correction protocol. MicroRNA expression
ratios with P values of 0.05 and log2 changes of less than or equal
to 0.586 or log2 changes of 0.586 were considered as repression
or overexpression, respectively.
RESULTS
Evaluation of I/R Injury and Cardioprotection
To confirm the cardioprotective effect of preconditioning
and postconditioning in the present study, infarct size and LDH
release were measured after I/R. Both ischemic precondition-
ing and ischemic postconditioning significantly decreased in-
farct size as measured at the 120th min of reperfusion com-
pared with the I/R group (Table 1). LDH release measured in
the first 5 min of reperfusion after 30 min of ischemia was
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significantly reduced in both ischemic pre- and postcondition-
ing groups (Table 1). Neither heart rate nor coronary flow was
affected significantly by any of the interventions (Table 1).
Global Expression Changes of MicroRNAs
To determine microRNAs in 1) time-matched nonischemic
control, 2) I/R, 3) preconditioning  I/R, and 4) I/R 
postconditioning groups, microRNAs were isolated from the
anterior wall of left ventricles after 2 h of reperfusion from all
groups. Of the total 350 different rat microRNAs studied, 147
microRNAs in the time-matched nonischemic control group,
154 microRNAs in the I/R group, 160 microRNAs in the
preconditioning group, and 156 microRNAs in the postcondi-
tioning group showed expression, respectively.
Identification of MicroRNAs Associated With I/R Injury
To determine microRNAs associated with I/R injury,
microRNA expression induced in the I/R group was compared with
the time-matched nonischemic control group as well as in
ischemic preconditioning and postconditioning groups. Eight
different microRNAs (microRNA-125a-5p, microRNA-322*,
microRNA-331, microRNA-378*, microRNA-494, microRNA-
652, microRNA-877, and microRNA-92a) were significantly
altered by I/R compared with the time-matched nonischemic
control group, and their alterations were not affected signifi-
cantly either by pre- or postconditioning, which represented
microRNAs associated with I/R injury alone without being
associated with cardioprotective signaling (Fig. 2.).
Identification of MicroRNAs Associated With
Cardioprotection by Ischemic Pre- and/or Postconditioning
To assess cardioprotective microRNAs associated with isch-
emic preconditioning, we analyzed expression alterations (in-
cluding the direction of changes) induced by ischemic precon-
ditioning followed by I/R compared with the I/R and time-
matched nonischemic control groups, respectively. We found
three different microRNAs that were significantly upregulated
by preconditioning compared with both the time-matched non-
ischemic control group and the I/R group (microRNA-139-5p,
microRNA-192, and microRNA-212; Fig. 3A). There was also
one microRNA that was significantly upregulated by I/R com-
pared with time-matched nonischemic controls; however, pre-
conditioning inhibited this alteration, i.e., downregulated this
alteration compared with I/R (microRNA-487b; Fig. 3B). We
considered these microRNAs to be associated with the cardio-
protective mechanisms of preconditioning.
To further assess cardioprotective microRNAs, the effect of
ischemic postconditioning on myocardial microRNA expres-
sion was determined. We found three microRNAs that were
not affected by I/R itself compared with nonischemic controls;
however, their expression was significantly upregulated by the
subsequent postconditioning stimulus compared with the I/R
group (microRNA-1, microRNA let-7i, and microRNA let-7e;
Fig. 4A). There were also six different microRNAs that were
significantly altered (up- or downregulated) by I/R compared
with time-matched nonischemic controls; however, postcondi-
tioning significantly inhibited these alterations (microRNA
let-7b, microRNA-181a, microRNA-208, microRNA-328,
microRNA-335, and microRNA-503; Fig. 4B). We considered
these nine microRNAs to be associated with the cardioprotec-
tive mechanisms of postconditioning.
We found five different microRNAs (microRNA-188, mi-
croRNA-532-3p, microRNA-125b*, microRNA139-3p, and
microRNA-320) that showed similar expression patterns due to
both ischemic preconditioning and postconditioning according
to the following results. Both ischemic preconditioning and
ischemic postconditioning significantly inhibited I/R-induced
downregulation of microRNA-125b*, microRNA-139-3p, and
microRNA-320 (Fig. 5B). In the case of microRNA-188
and microRNA-532-3p, both pre- and postconditioning in-
duced significant upregulation compared with I/R; however,
I/R alone did not affect the expression of these microRNAs
(Fig. 5A). We considered these five microRNAs to play a
pivotal role in endogenous cardioprotective signaling in both
pre- and postconditioning.
Validation of Microarray Data by Quantitative Real-Time
PCR
To confirm the microarray data, we measured the expression
of 12 randomly selected microRNAs using quantitative real-
time PCR. The expression changes of 10 microRNAs were
confirmed by quantitative real-time PCR and showed good
reliability of the microarray data (Table 2). In addition, quan-
titative real-time PCR experiments were performed in the case
of microRNA-125b*, which showed the most pronounced
alterations due to I/R and pre- and postconditioning as assessed
by microarray. The quantitative real-time PCR results con-
firmed the microarray data (Table 2).
Identification of ProtectomiRs
To identify protectomiRs, we systematically compared mi-
croRNA changes and the direction of their changes in all
Table 1. Markers of myocardial tissue injury
Time-Matched Nonischemic
Control Group
Ischemia-Reperfusion
Group
Ischemic Preconditioning
Group
Ischemic Postconditioning
Group
Animal weight, g 284  10 282  11 275 9 276  4
Area at risk, % N/A 37.4  1.7 40.1 4.3 43.3  3.5
Infarct size (%) N/A 48.3 3.5 15.3 3.7* 21.7  1.5*
Lactate dehydrogenase release, mU·min1·g1 N/A 3.31 0.45 0.82 0.16* 1.51  0.38*
Heart rate, beats/min 274 8 283  12 279 8 295  14
Coronary flow, ml/min 10.1 1.1 9.9  0.9 10.8  0.7 12.2  1.4
Values are means  SE. The area at risk and infarct size were measured after 120 min of reperfusion. Lactate dehydrogenase release was measured from
coronary effluent collected during the first 5 min of reperfusion. The heart rate and coronary flow data presented here were measured at the end of the perfusion
protocols. N/A, not applicable. *P  0.05 vs. the ischemia-reperfusion group.
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groups. Based on the comparative data, potential protectomiRs
were classified into six theoretical categories, as described in
METHODS (Fig. 6). The protectomiRs identified here belonged to
three of the six theoretical categories, as follows. Mimics of
microRNA-125b*, microRNA-139-3p, microRNA-320, microRNA
let-7b, microRNA-181a, microRNA-328, microRNA-335, and
microRNA-503 were considered as protectomiRs as these
microRNAs were downregulated by I/R compared with time-
matched nonischemic controls and their downregulation was
inhibited by ischemic pre- and/or postconditioning. Further
mimics of microRNA-188, microRNA-532-3p, microRNA-
212, microRNA-192, microRNA-139-5p, microRNA let-7e,
microRNA let-7i, and microRNA-1 were considered as pro-
tectomiRs as these microRNAs were not affected by I/R
1
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Log2 change
0 2 3 4-1-2
rno-miR-92a
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Fig. 2. Cardiac microRNAs (miR) associated with
I/R injury. This graph shows microRNAs that were
significantly changed by I/R compared with time-
matched nonischemic controls but neither pre- nor
postconditioning influenced their changes due to
I/R. This shows that these microRNAs were asso-
ciated with I/R and unaffected by endogenous car-
dioprotective mechanisms. Bars show alterations in
microRNA expression in I/R versus time-matched
nonischemic controls (IR/C), preconditioning ver-
sus time-matched nonischemic controls (PRE/C),
postconditioning versus time-matched nonischemic
controls (POST/C), preconditioning versus I/R
(PRE/IR), and postconditioning versus I/R (POST/
IR). Values are log2 expression changes  SD.
*P  0.05 and a log2 change of greater than or
equal to 0.585.
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Fig. 3. MicroRNAs associated with cardioprotection by ischemic precondi-
tioning. A: microRNAs that were significantly induced by preconditioning
compared with both I/R and time-matched nonischemic controls, demonstrat-
ing that these microRNAs are specifically induced by preconditioning.
B: microRNA-487b, which was significantly upregulated by I/R compared with
time-matched nonischemic controls; however, preconditioning significantly
inhibited its expression change due to I/R compared with nonischemic con-
trols. Bars show alterations in microRNA expression in I/R versus time-
matched nonischemic controls, preconditioning versus time-matched nonisch-
emic controls, postconditioning versus time-matched nonischemic controls,
preconditioning versus I/R, and postconditioning versus I/R. Values are log2
expression changes  SD. *P  0.05 and a log2 change of greater than or
equal to 0.585.
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Fig. 4. MicroRNAs associated with cardioprotection by ischemic postcondi-
tioning. A: microRNAs that were significantly induced by postconditioning
compared with I/R, demonstrating that these microRNAs are specifically
induced by postconditioning. B: microRNAs that were significantly affected by
I/R compared with time-matched nonischemic controls; however, their alter-
ations were significantly inhibited postconditioning. Bars show alterations in
microRNA expression in I/R versus time-matched nonischemic controls,
preconditioning versus time-matched nonischemic controls, postconditioning
versus time-matched nonischemic controls, preconditioning versus I/R, and
postconditioning versus I/R. Values are log2 expression changes  SD. *P 
0.05 and a log2 change of greater than or equal to 0.585.
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compared with time-matched nonischemic controls; however,
they were upregulated by ischemic pre- and/or postcondition-
ing compared with I/R. AntagomiRs of microRNA-487b and
microRNA-208 were considered as protectomiRs as these
microRNAs were upregulated by I/R compared with time-
matched nonischemic controls and their upregulation was in-
hibited by ischemic pre- and/or postconditioning.
Validation of Cardiocytoprotection by ProtectomiRs in
Cardiomyocytes Subjected to Simulated I/R
Based on the microRNA microarray results, several microRNAs
were identified to be associated with cardioprotection by
pre- and/or postconditioning. To further validate the possi-
ble causative relationship between the affected microRNAs
and cytoprotection, a postconditioning-associated mimick
protectomiR (rno-let7b) and a preconditioning-associated
mimick protectomiR (rno-miR-139-5p) as well as an inhib-
itor protectomiR (rno-miR-487b) and a mimick protectomiR
associated with both pre- and postconditioning-induced car-
dioprotection (rno-miR-125b*) were selected for further
study in cardiac myocytes subjected to simulated I/R. Trans-
fection of cardiomyocytes with any of the four selected
protectomiRs significantly decreased cardiomyocyte cell
death due to simulated I/R (Fig. 7).
DISCUSSION
In the present study, we have shown using a microarray
containing all 350 rat microRNAs available in Sanger miRBase
(version 10.1) that in the early phase of I/R injury (i.e., at 2 h
of reperfusion) the microRNA expression pattern is altered in
the rat heart, which is significantly influenced by preceding
preconditioning and/or subsequent postconditioning stimuli.
Moreover, by a systematic comparison of microRNA expres-
sion changes and the direction of the changes induced by I/R
with or without pre- or postconditioning, we revealed possible
causative relationships between microRNA changes and en-
dogenous cardioprotection. This is the first demonstration that
ischemic pre- and postconditioning significantly affect the
I/R-induced global microRNA expression pattern. Further-
more, we validated the cardiocytoprotective effect of four of
the potential cardioprotective microRNAs (i.e., the mimic of
microRNA-125b*, microRNA let-7b, microRNA-139-5p, and
inhibitor of microRNA-487b) in cardiomyocytes subjected to
simulated I/R in vitro. Therefore, we identified specific cardio-
protective microRNAs as potential therapeutic targets, the modula-
tion of which with specific microRNA mimics or antagomiRs may
provide cardioprotection. These microRNA mimics or antagomiRs
are commonly termed here as protectomiRs.
MicroRNAs Associated With I/R Injury
Some studies have previously reported alterations of global
microRNA expression after myocardial infarction in different
animal models; nevertheless, the majority of these studies
focused on late stages of infarction (days after coronary artery
ligation), thereby showing the possible involvement of
microRNAs in cardiac remodeling and heart failure (32, 34, 39).
However, there is limited information regarding microRNA
alterations in the first few hours of I/R injury, when irreversible
processes of cell injury are already triggered (11, 31, 41).
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Fig. 5. MicroRNAs associated with cardioprotection by both preconditioning
and postconditioning. A: microRNA changes induced by pre- and postcondi-
tioning stimuli per se. B: microRNAs that were significantly changed by I/R
compared with time-matched nonischemic controls; however, both precondi-
tioning and postconditioning significantly inhibited their expression changes
due to I/R. This shows that these microRNAs are associated with cardiopro-
tection by both pre- and postconditioning via a reversal of the deleterious
mechanisms of I/R. Bars show alterations in microRNA expression in I/R
versus time-matched nonischemic controls, preconditioning versus time-
matched nonischemic controls, postconditioning versus time-matched nonisch-
emic controls, preconditioning versus I/R, and postconditioning versus I/R.
Values are log2 expression changes  SD. *P  0.05 and a log2 change of
greater than or equal to 0.585.
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In the present study, we considered microRNAs to be associ-
ated with acute I/R injury (i.e., 2 h of reperfusion) when an
alteration in the expression of a specific microRNA was signifi-
cantly changed by I/R compared with time-matched nonischemic
controls but when neither preceding preconditioning nor subse-
quent postconditioning influenced the I/R-induced change of the
particular microRNA. This shows that these microRNAs were
associated with I/R but unaffected by endogenous cardioprotec-
tive mechanisms. Such an expression pattern was characteristic in
the case of eight different microRNAs (microRNA-125a-5p, mi-
croRNA-322*, microRNA-331, microRNA-378*, microRNA-
494, microRNA-652, microRNA-877, and microRNA-92a). Ac-
cordingly, microRNA-92a, microRNA-494, and microRNA-378*
have been previously described to be affected by ischemia in
different tissues of rodents (2, 26, 41). Nevertheless, to date, little
is known on the role of these microRNAs in acute I/R injury.
MicroRNAs Associated With Ischemic Preconditioning
Our present study is the first in the literature focusing on the
global microRNA expression pattern in the early phase of I/R
injury preceded by ischemic preconditioning. Here, we found
three different microRNAs (microRNA-139-5p, microRNA-192,
and microRNA-212) that were significantly upregulated by pre-
conditioning compared with both the I/R and time-matched non-
ischemic control groups, suggesting that these microRNAs are
specifically induced by preconditioning stimuli. Furthermore, we
found a single microRNA (i.e., microRNA-487b) that was sig-
nificantly upregulated by I/R; however, preconditioning inhib-
ited its upregulation, thereby demonstrating a specific counter-
regulation of this microRNA in I/R by preceding precondition-
ing. By this approach, we revealed a possible causative
relationship between these microRNAs and the cardioprotec-
tive effect of preconditioning. To further validate the possible
causative relationships, we selected the mimick of microRNA-
139-5p and inhibitor of microRNA-487b as potential precon-
ditioning-related protectomiRs for transfection into primary
neonatal cardiomyocytes subjected to simulated I/R and found
that both the mimick of microRNA-139-5p and inhibitor of
microRNA-487b were cardiocytoprotective. These results con-
firmed a causative relationship between microRNAs identified
by the above-mentioned approach and cardioprotection.
Among the microRNAs affected by ischemic precondition-
ing in the present study are several ones with unknown func-
tion. For instance, the function of microRNA-139 has been
demonstrated only in mouse hepatocytes so far (21), i.e.,
microRNA-139 decreased the amount of FoxO1 protein, a key
factor in the regulation of cardiomyocyte autophagy (33).
Autophagy, on the other hand, has been shown to be involved
in ischemic preconditioning-induced cardioprotection (25).
In a late preconditioning model, Yin et al. (44) investigated
the involvement of microRNA-1, microRNA-21, and microRNA-
24 in mice; however, we could not demonstrate a role of these
microRNAs in our classic preconditioning model. Wang et al.
(42) detected significant microRNA-144 and microRNA-451
upregulation immediately after preconditioning stimuli. More-
over, they showed that infarct size in microRNA-144/451
knockout mice is higher and cannot be preconditioned (42). In
our present data set, microRNA-451 also showed some upregu-
lation due to preconditioning compared with I/R; however, the
level of upregulation did not reach statistical significance.
These discrepancies could be due to differences in species and
in the time of tissue sampling after ischemia.
MicroRNAs Associated With Ischemic Postconditioning
The present study is the first in the literature focusing on
global microRNA expression changes in the early phase of
ischemic postconditioning-induced protection. Here, we iden-
tified nine different microRNAs (microRNA-1, microRNA
let-7i, microRNA let-7e, microRNA let-7b, microRNA-181a,
microRNA-208, microRNA-328, microRNA-335, and
microRNA-503) that were significantly affected by subsequent
postconditioning compared with I/R, showing that these
microRNAs are specifically regulated by the postconditioning
stimuli. We found six different microRNAs (microRNA let-7b,
microRNA-181a, microRNA-208, microRNA-328, mi-
croRNA-335, and microRNA-503) that were significantly al-
tered (up- or downregulated) by I/R compared with time-
matched nonischemic controls; however, postconditioning sig-
Table 2. Validation of the microarray data with quantitative real-time PCR
microRNA Name Chip Result Quantitative Real-Time PCR Result Confirmed
Ischemia-reperfusion group versus time-matched nonischemic control group
rno-let-7c 0.92  0.38 1.25  0.20 Yes
rno-let-7d 0.66  0.24 1.65  1.02 Yes
rno-miR-92a 0.82  0.25 0.69 0.04 No
rno-miR-19a 0.60 0.11 1.14  0.72 Yes
rno-miR-19b 0.70 0.25 1.33  0.60 Yes
rno-miR-208 0.70 0.30 1.30  0.53 Yes
rno-miR-30c 0.32 0.14 0.07  0.54 Yes
rno-miR-335 0.98  0.49 1.91  0.83 Yes
rno-miR-125b* 4.53  0.26 5.02  0.29 Yes
Ischemic preconditioning group versus ischemia-reperfusion group
rno-miR-320 0.74 0.13 1.75  0.93 Yes
rno-miR-335 0.65  0.4 0.19 0.32 No
rno-miR-125b* 4.39 0.25 4.66  0.36 Yes
Ischemic postconditioning group versus ischemia-reperfusion group
rno-miR-1 0.74 0.26 1.93  0.47 Yes
rno-miR-335 1.36 0.43 1.93  0.75 Yes
rno-miR-125b* 4.03 0.28 0.92  0.29 Yes
Values are means  SD of log2 expression changes.
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nificantly inhibited these alterations. These findings
demonstrate that I/R-induced expression changes of these six
different microRNAs are specifically counterregulated by sub-
sequent postconditioning stimuli. In addition, we found three
different microRNAs (microRNA-1, microRNA let-7i, and
microRNA let-7e) that were not affected by I/R compared with
nonischemic controls; however, these microRNAs were up-
regulated due to postconditioning compared with I/R. By this
approach, we revealed a possible causative relationship be-
tween these microRNAs and the cardioprotective effect
of postconditioning. To further validate this, we selected
microRNA let-7b as a potential postconditioning-related protec-
tomiR for transfection into primary neonatal cardiomyocytes
subjected to simulated I/R and found that microRNA let-7b
was cardiocytoprotective. This result confirmed a causative
relationship between microRNAs identified by the above-
mentioned approach and cardioprotection.
The exact role of most of the postconditioning-related pro-
tectomiRs in cardioprotection is unclear, but some of these
microRNAs have been previously studied in the heart. He et al.
(24) showed that microRNA-1 and microRNA-133a were in-
volved in the cardioprotective effect of ischemic postcondi-
tioning in the rat and found that these microRNAs were
capable of decreasing cardiomyocyte apoptosis in vitro. Here,
we found a similar upregulation of microRNA-1 after subse-
quent postconditioning stimuli. This microRNA has been
shown to be involved in the regulation of apoptotic signaling
by modulating the phosphatase and tensin homolog/Akt path-
way (20), which is known to be a major participant of I/R
injury and one of the intracellular mediator of cardioprotective
signaling (18, 23). In the present study, microRNA-208 was
significantly upregulated by I/R compared with nonischemic
controls, which was inhibited by subsequent postconditioning
stimuli. A similar upregulation of myocardial microRNA-208
has been previously described by Bostjancic et al. (3, 4) after
myocardial infarction in humans. This microRNA is encoded
in an intron of the 	-myosin heavy chain 6 gene, and it is
believed to be cardiac specific (38). MicroRNA-208 mediates
Fig. 6. Selection process of cardiac protectomiRs. MicroRNAs that were significantly affected by ischemic preconditioning (IPRE) and/or ischemic
postconditioning (IPOST) compared with I/R alone were identified first. These microRNAs were then divided into three groups according to the effect of I/R
compared with time-matched nonischemic controls and further subdivided into two additional categories according to the direction of microRNA expression
changes, thereby yielding the following six categories. Category 1 comprised microRNAs that were downregulated by I/R compared with time-matched
nonischemic controls, but their down-regulation was inhibited by ischemic preconditioning and/or postconditioning. They were considered to be associated with
the cardioprotective mechanism of ischemic preconditioning and/or postconditioning; therefore, these microRNAs or their mimics are considered as
protectomiRs. Category 2 comprised microRNAs that were downregulated by I/R compared with time-matched nonischemic controls, but their down-regulation
was further enhanced by ischemic preconditioning and/or ischemic postconditioning. They were considered to be associated with the cardioprotective mechanism
of ischemic preconditioning and/or postconditioning; therefore, the antagomiRs of these microRNAs can be also considered as protectomiRs. However, no
example of this microRNA group was found. Category 3 comprised microRNAs that were upregulated by I/R compared with time-matched nonischemic controls,
but their upregulation was inhibited by ischemic preconditioning and/or postconditioning. They were considered to be involved in the development of I/R injury;
therefore, the antagomiRs of these microRNAs can be also considered as protectomiRs. Category 4 comprised microRNAs that were upregulated by I/R
compared with time-matched nonischemic controls, but their upregulation was further enhanced by ischemic preconditioning and/or postconditioning. They were
considered to be associated with the cardioprotective mechanism of ischemic preconditioning and/or postconditioning; therefore, these microRNAs or their
mimics are considered as protectomiRs. Category 5 comprised microRNAs that were not affected by I/R alone compared with time-matched nonischemic controls
but were significantly upregulated by ischemic preconditioning and/or postconditioning. They were considered to be associated with the cardioprotective
mechanism of ischemic preconditioning and/or postconditioning; therefore, these microRNAs or their mimics are considered as protectomiRs. Category 6
comprised a group of microRNAs not affected by I/R alone compared with time-matched nonischemic controls, but their expression was downregulated by
ischemic preconditioning and/or postconditioning. Inhibition of these microRNAs was considered to be involved in the cardioprotective mechanism of ischemic
preconditioning and/or postconditioning; therefore, the antagomiRs of these microRNAs can be also considered as protectomiRs.
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downregulation of the 	-myosin heavy chain gene and up-
regulation of the 
-myosin heavy chain (37), which are both
involved in the development of hypertrophic response (43). In
addition, some other targets of microRNA-208 have been
determined by Callis et al. (7), including myostatin, a negative
regulator of muscle growth and hypertrophy. These results,
including those in the present study, suggest that an antagomiR
of microRNA-208 could be a promising protectomiR, having
additional therapeutic value in cardiac hypertrophy. The 15
different protectomiRs identified in the present study to be
involved in the cardioprotective effect of postconditioning
represent a therapeutic target group against reperfusion injury.
MicroRNAs Commonly Associated With Cardioprotection by
Both Pre- and Postconditioning
Our present study is the first to identify microRNAs commonly
associated with cardioprotection induced by both pre- and post-
conditioning. These five different microRNAs (microRNA-188,
microRNA-532-3p, microRNA-125b*, microRNA-139-3p, and
microRNA-320) represent especially important therapeutic targets for
ischemia- as well as reperfusion-induced pathologies. In case of
microRNA-188 and microRNA-532-3p, both pre- and postcondition-
ing significantly induced upregulation compared with I/R; however,
I/R alone did not affect the expression of these microRNAs. This is
the first demonstration that microRNA-188 and microRNA-532-3p
are specifically associated with both pre- and postconditioning
stimuli. However, there are no data in the literature on the
mRNA targets of microRNA-188 and microRNA-532-3p in
the heart. In the case of microRNA-125b*, microRNA-139-3p,
and microRNA-320, this is the first demonstration that both
preceding preconditioning and subsequent postconditioning
stimuli resulted in a significant reversal of I/R-induced mi-
croRNA expression changes, suggesting the prominent role of
these microRNAs in cardioprotective signaling. However,
there are no data on the role of microRNA-139-3p, whereas
there are limited data on microRNA-320 and microRNA-
125b* in cardiac pathologies (6, 31). Ren et al. (31) showed
that microRNA-320 was significantly downregulated in an ex
vivo mouse model of 45 min of global ischemia and 2 h of
reperfusion as well as in an in vivo mouse model of 30 min of
coronary occlusion and 24 h of reperfusion. In the present
study, we detected a similar downregulation of microRNA-320
after acute I/R. However, we have also shown here that both
preconditioning and postconditioning inhibited the I/R-induced
downregulation of microRNA-320, indicating that this mi-
croRNA plays an important role in cardioprotection. MicroRNA-
125b* showed the most significant changes in the present study,
i.e., more than 20-fold down-regulation after I/R, while both
preceding preconditioning and subsequent postconditioning
stimuli markedly inhibited its downregulation. The exact role
of microRNA-125b in cardioprotective cellular signaling re-
mains to be investigated. Nevertheless, it should be mentioned
that Busk et al. (6) reported a significant upregulation of
microRNA-125b during the early hypertrophic growth in rat
hearts after aortic banding.
According to the above-described approach, we revealed a
causative relationship between microRNA-188, microRNA-
532-3p, microRNA-125b*, microRNA-139-3p, and microRNA-
320 and the cardioprotective effect of both pre- and postcon-
ditioning. To further validate these causative relationships, we
selected microRNA-125b* as a potential pre- and postcondi-
tioning-related protectomiR for transfection into primary neo-
natal cardiomyocytes subjected to simulated I/R and found that
microRNA-125b* was cardiocytoprotective. This result further
confirmed a causative relationship between microRNAs iden-
tified by the above-mentioned approach and cardioprotection.
ProtectomiRs
In the present study, we report a novel approach to identify
therapeutically applicable microRNAs with cardioprotective
features. The analysis of the direction of microRNA changes
due to pre- and/or postconditioning allowed the identification
of mimics or antagomiRs of specific microRNAs, which were
termed here as protectomiRs. Interestingly, all of the identified
microRNA belonged to three major categories of the theoret-
ically possible six categories, as described in METHODS. More-
over, the majority (18 of 20) of the identified protectomiRs
were microRNA mimics, suggesting that the loss of specific
microRNAs in the ischemic myocardium may play a role in I/R
injury.
Limitations of the Study
In the present study, global microRNA expression was
investigated in a single time point upon reperfusion; therefore,
the time course of changes in microRNA expressions remained
unknown. Thirty minutes of coronary occlusion followed by
120 min of reperfusion, when microRNA expression was
measured, is considered an early phase of cell injury due to
necrotic and/or apoptotic processes (28). However, it cannot be
excluded that early cell death processes might affect mi-
croRNA alterations induced by I/R injury and cytoprotection
by pre- and postconditioning.
Although we identified several protectomiRs in the present
study, investigation of the exact role of each protectomiR in
cardioprotective signaling was outside of the scope of this
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Fig. 7. Cardiocytoprotection by selected protectomiRs. Transfection of primary
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study. Since the present project was performed in rats, deter-
mination of the translational value of the results needs further
study. Moreover, it has to be noted that whereas the efficacy of
preconditioning in humans is well established, the efficacy of
postconditioning in humans is largely inconclusive as there are
several negative data, probably due to different postcondition-
ing protocols and the presence of multiple confounding factors
(for extensive reviews, see Refs. 17, 22, and 30).
Conclusions
This is the first comprehensive study on the global
microRNA expression pattern of the heart in response to I/R
with or without preceding preconditioning or subsequent post-
conditioning using a microarray of 350 different microRNAs.
Here, we show that I/R induces acute alterations in the expres-
sion of several microRNAs of known and yet unknown func-
tion in the rat heart and that many of these alterations are
significantly influenced by preceding preconditioning and/or
subsequent postconditioning stimuli. Moreover, by a system-
atic comparative analysis of global microRNA expression
patterns in time-matched nonischemic control, I/R, ischemic
preconditioning, and ischemic postconditioning groups,
microRNAs associated with endogenous cardioprotection can
be identified.
These microRNAs can serve as potential targets for modu-
lation by specific microRNA mimics or antagomiRs (termed
protectomiRs) to achieve cardioprotection.
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